Based on the key indicators obtained from InnovAge Holding's historical financial statements, InnovAge Holding Corp may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, InnovAge Holding's Property Plant Equipment is fairly stable compared to the past year. Current Deferred Revenue is likely to climb to about 18.3 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 70.8 M in 2024. Key indicators impacting InnovAge Holding's financial strength include:
The financial analysis of InnovAge Holding is a critical element in measuring its lifeblood. Investors should not minimize InnovAge Holding's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income
(20.27 Million)
InnovAge
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Sale Purchase Of Stock
Change To Inventory
Change In Cash
Net Borrowings
Total Cashflows From Investing Activities
Other Cashflows From Financing Activities
Depreciation
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Change To Operating Activities
Net Income
Total Cash From Financing Activities
Other Cashflows From Investing Activities
Change To Netincome
Change To Liabilities
Investments
End Period Cash Flow
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Non Cash Items
Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Other Liab
Net Tangible Assets
Retained Earnings
Accounts Payable
Cash
Other Assets
Long Term Debt
Net Receivables
Good Will
Inventory
Other Current Assets
Total Liab
Short Long Term Debt
Total Current Assets
Short Term Debt
Intangible Assets
Common Stock
Property Plant Equipment
Short Long Term Debt Total
Property Plant And Equipment Net
Current Deferred Revenue
Net Debt
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Capital Lease Obligations
Other Stockholder Equity
Net Invested Capital
Long Term Investments
Property Plant And Equipment Gross
Non Current Liabilities Other
Net Working Capital
Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Operating Income
Net Income From Continuing Ops
Ebit
Research Development
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Net Income Applicable To Common Shares
Income Tax Expense
Tax Provision
Net Interest Income
Depreciation And Amortization
Selling And Marketing Expenses
Other Operating Expenses
Ebitda
Reconciled Depreciation
Minority Interest
Probability Of Bankruptcy
Understanding current and past InnovAge Holding Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of InnovAge Holding's financial statements are interrelated, with each one affecting the others. For example, an increase in InnovAge Holding's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in InnovAge Holding's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of InnovAge Holding Corp. Check InnovAge Holding's Beneish M Score to see the likelihood of InnovAge Holding's management manipulating its earnings.
InnovAge Holding Stock Summary
InnovAge Holding competes with Addus HomeCare, Morningstar Unconstrained, SEI Investments, Goosehead Insurance, and Koppers Holdings. InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado. InnovAge Holding operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 2000 people.
The reason investors look at the income statement is to determine what InnovAge Holding's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining InnovAge Holding's current stock value. Our valuation model uses many indicators to compare InnovAge Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across InnovAge Holding competition to find correlations between indicators driving InnovAge Holding's intrinsic value. More Info.
InnovAge Holding Corp is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . At this time, InnovAge Holding's Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value InnovAge Holding by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
InnovAge Holding Corp Systematic Risk
InnovAge Holding's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. InnovAge Holding volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on InnovAge Holding Corp correlated with the market. If Beta is less than 0 InnovAge Holding generally moves in the opposite direction as compared to the market. If InnovAge Holding Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one InnovAge Holding Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of InnovAge Holding is generally in the same direction as the market. If Beta > 1 InnovAge Holding moves generally in the same direction as, but more than the movement of the benchmark.
InnovAge Holding Thematic Clasifications
InnovAge Holding Corp is part of Healthcare investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in InnovAge Holding Stock are looking for potential investment opportunities by analyzing not only static indicators but also various InnovAge Holding's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of InnovAge Holding growth as a starting point in their analysis.
InnovAge Holding November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of InnovAge Holding help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of InnovAge Holding Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of InnovAge Holding Corp based on widely used predictive technical indicators. In general, we focus on analyzing InnovAge Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build InnovAge Holding's daily price indicators and compare them against related drivers.
When running InnovAge Holding's price analysis, check to measure InnovAge Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InnovAge Holding is operating at the current time. Most of InnovAge Holding's value examination focuses on studying past and present price action to predict the probability of InnovAge Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InnovAge Holding's price. Additionally, you may evaluate how the addition of InnovAge Holding to your portfolios can decrease your overall portfolio volatility.